Sorafenib Pharmagen Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sorafenib pharmagen

pharmagen cz s.r.o., Česká republika - sorafenib - 44 - cytostatica

Sorafenib Zentiva Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sorafenib zentiva

zentiva, k.s., Česká republika - sorafenib - 44 - cytostatica

Comirnaty Európska únia - slovenčina - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcíny - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. použitie tejto vakcíny by mali byť v súlade s oficiálne odporúčania.

Leqvio Európska únia - slovenčina - EMA (European Medicines Agency)

leqvio

novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - Činidlá modifikujúce lipidy - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.

Stelfonta Európska únia - slovenčina - EMA (European Medicines Agency)

stelfonta

qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - psy - pri liečbe non-resectable, non-metastatické (ktorÍ inscenácia) podkožného žírnych buniek nádorov sa nachádza v distálnej koleno alebo päty, a non-resectable, non metastatickým kožných žírnych buniek nádorov u psov.

Gletor 40 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

gletor 40 mg

glenmark pharmaceuticals s.r.o. - atorvastatín - 31 - hypolipidaemica

SORTIS 40 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sortis 40 mg

upjohn eesv, holandsko - atorvastatín - 31 - hypolipidaemica

SORTIS 80 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sortis 80 mg

upjohn eesv, holandsko - atorvastatín - 31 - hypolipidaemica